These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1841270)

  • 1. Antisense oligodeoxynucleoside methylphosphonate inhibition of mouse c-myc p65 protein expression in E mu-c-myc transgenic mice.
    Wickstrom E; Bacon TA; Wickstrom EL; Werking CM; Palmiter RD; Brinster RL; Sandgren EP
    Nucleic Acids Symp Ser; 1991; (24):151-4. PubMed ID: 1841270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of c-MYC antigen expression in lymphocytes of Emu-c-myc transgenic mice treated with anti-c-myc DNA methylphosphonates.
    Wickstrom E; Bacon TA; Wickstrom EL
    Cancer Res; 1992 Dec; 52(24):6741-5. PubMed ID: 1458461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
    Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
    J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines.
    Roland J; Morello D
    Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cis-acting elements known to regulate c-myc expression ex vivo are not sufficient for correct transcription in vivo.
    Lavenu A; Pournin S; Babinet C; Morello D
    Oncogene; 1994 Feb; 9(2):527-36. PubMed ID: 8290263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
    Chavany C; Connell Y; Neckers L
    Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
    Su ZZ; Yemul S; Stein CA; Fisher PB
    Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
    Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
    Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased transcription of the E mu-myc transgene and mRNA stabilisation produce only a modest elevation in Myc protein.
    Colley SM; Tilbrook PA; Klinken SP
    Oncogene; 1997 Jun; 14(22):2735-9. PubMed ID: 9178772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
    Cutrona G; Carpaneto EM; Ponzanelli A; Ulivi M; Millo E; Scarfì S; Roncella S; Benatti U; Boffa LC; Ferrarini M
    Cancer Res; 2003 Oct; 63(19):6144-8. PubMed ID: 14559793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice.
    Nussenzweig MC; Schmidt EV; Shaw AC; Sinn E; Campos-Torres J; Mathey-Prevot B; Pattengale PK; Leder P
    Nature; 1988 Dec; 336(6198):446-50. PubMed ID: 3143076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
    Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI
    J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA.
    Fujimoto K; Takahashi M
    Biochem Biophys Res Commun; 1997 Dec; 241(3):775-81. PubMed ID: 9434785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.
    Iversen PL; Arora V; Acker AJ; Mason DH; Devi GR
    Clin Cancer Res; 2003 Jul; 9(7):2510-9. PubMed ID: 12855625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antisense oligonucleotides inhibit c-myc and PCNA expression in the vascular smooth muscle cells].
    Bian J; Zhang B; Chen S
    Zhonghua Yi Xue Za Zhi; 1999 Jan; 79(1):10-4. PubMed ID: 11600998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart-specific inhibition of protooncogene c-myc attenuates cold-induced cardiac hypertrophy.
    Bello Roufai M; Li H; Sun Z
    Gene Ther; 2007 Oct; 14(19):1406-16. PubMed ID: 17637797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
    Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
    Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines.
    Li BD; Budnick RM; Russo CA; Anderson GR; Stewart CC
    J Surg Res; 1995 Oct; 59(4):485-92. PubMed ID: 7564322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicopy c-Myc transgene as a nuclear label: overgrowth of Myctg50 cells in allophenic mice.
    Augustin M; Klopp N; Ewald K; Jockusch H
    Cell Biol Int; 1998; 22(6):401-11. PubMed ID: 10328848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.